What we do
We work with one of the most important forces in healthcare: the Patient Movement.
■ Two decades of experience
■ Independent research
■ Database of 40,000 patient groups worldwide
■ Working in 23 languages
■ Analyses based on geographic regions and therapy areas
■ Feedback from 2400+ patient groups in 2024; a record number
■ An extensive evidence base of patient-group views
■ Identifying strategic actions for individual companies
■ This year, PatientView received a record 2,500+ survey responses from patient groups across the world.
The views of patients and patient groups are becoming more central to every action that pharmaceutical companies take—from selecting which treatments address patients’ unmet needs, to co-creating user-friendly patient information.
Patients and patient groups accordingly need a platform to share their opinions on the pharmaceutical industry, and to offer up their ideas about how individual pharmaceutical companies can improve.
Featured report
What Companies Say
Alongside PatientView's 2025/26 annual survey, pharma provided their own perspectives on patient-group relationships — based on their own experiences, and with their own case studies — as part of this new report.
Latest Blogs
World Prostate Cancer Day 2026: The need for improved global screening
June 2026: Prostate cancer remains one of the most significant global health challenges. It is the most frequently diagnosed cancer in men in 112 countries, and the leading cause of cancer death among men in 48 countries. In 2022 alone, there… Continue reading “World Prostate Cancer Day 2026: The need for improved global screening”
ViiV Healthcare’s insights on its patient-group relations
May 2026: ViiV Healthcare, the global specialist company in HIV care, has ranked #1 for the 13th consecutive year in the PatientView Corporate Reputation of Pharma survey. As per the… Continue reading “ViiV Healthcare’s insights on its patient-group relations”







